Come up with a name for your new list and we'll add to it:
BioOne raised a round of funding on , . Investors include
Mitsubishi UFJ Capital.
BioOne offers the Intercept Blood System, a system to inactivate pathogens and lymphocytes in blood products. The technology was developed by Cerus Corporation…